Abstract
There has long been recognition of the enormous and persistent personal and social consequences of mental illness. The chronicity of disorders such as schizophrenia and dementia, and the long-term if lower-level debilitation of depression and many neuroses, have substantial impacts on cognition, health, functioning and quality of life. They can leave many sufferers and their families with constrained, deprived, often devastated lives. The care of people with mental health problems in hospital or in community settings, support for their families and the treatment of symptoms as well as clinical and social sequelae generate considerable costs for health care, social services and other agencies. Directly or indirectly, there are also cost burdens for sufferers and their families. The consequences of mental illness, in other words, can be far-reaching and expensive.
Dr. Annette Donath made enormous contributions to the writing of this chapter and, but for various protocol considerations beyond her and my control, would have been a co-author. Dr. Thomas Becker and Klaudia Werth made very helpful comments on the penultimate draft of the manuscript. My thanks to them all. Some parts of this chapter are necessarily summary accounts of issues, methods or examples dealt with in more detail elsewhere (Knapp 1995).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
AOK-Bundesverband (1996) Krankheitsartenstatistik 1993. AOK-Bundesverband, Bonn
Audini, B, Marks IM, Connolly J, Lawrence RE, Watts V (1994) Home-based versus out-patient/in-patient care for people with serious mental illness. Br J Psychiatry 165: 204–210
Beck B (1996) The economics of ageing. The Economist (27th January 1996): 3–16
Beecham JK, Knapp MRJ (1992) Costing psychiatric interventions. In: Thornicroft G, Brewin C, Wing J (eds) Measuring mental health needs. Gaskell, London
Beecham JK, Knapp MRJ, Fenyo AJ (1991) Costs, needs and outcomes. Schizophr Bull 17: 427–439
⋆Beecham JK, Hallam A, Knapp MRJ, Baines B, Fenyo AJ, Asbury M (1997) Costing care in the hospital and in the community. In: Leff J (ed) Community care: illusion or reality? Wiley, Chichester
Beske F, Kern OA (1995) Kosten-Nutzen-Analyse der Behandlung dementieller Erkrankungen. Psycho 21: 724–730
Bundesministerium für Jugend, Familie, Frauen und Gesundheit (1986) Modellprogramm Psychiatrie — regionales Psychiatriebudget (181). Kohlhammer, Stuttgart
Bundesministerium für Jugend, Familie, Frauen und Gesundheit (eds) (1988) Empfehlungen der Expertenkommission der Bundesregierung zur Reform der Versorgung im psychiatrischen Bereich auf der Grundlage des Modellprogramms Psychiatrie der Bundesregierung. Bundesministerium für Jugend, Familie, Frauen und Gesundheit, Bonn
Brand FN, Smith RT, Brand PA (1977) Effect of economic barriers to medical care on patients’ noncompliance. Public Health Rep 92: 72–78
British Medical Association (1988) Philosophy and practice of medical ethics. British Medical Association, London
Chisholm D, Healey A, Knapp, MRJ (1997) QALYs and mental health care. Soc Psychiatry Psychiatr Epidemiol 32: 68–75
Commonwealth of Australia (1990) Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analyses. Department of Health, Housing and Community Services, Woden
Deutscher Bundestag (1975) Bericht über die Lage der Psychiatrie in der Bundesrepublik Deutschland. Deutscher Bundestag, Bonn
Diekstra RFW (1995) Depression and suicidal behaviours in adolescence: sociocultural and time trends. In: Rutter M (ed) Psychosocial disturbances in young people. Cambridge University Press, Cambridge
Dorwart RA (1990) Managed mental heath care: myths and realities in the 1990s. Hosp Community Psychiatry 41: 1087–1091
Drummond MF (1992) Cost-effectiveness guidelines for reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status? Health Econ 1: 85–92
⋆⋆Drummond M, Stoddart G, Torrance G (1987) Methods for the economic evaluation of health care programmes. Oxford Medical, Oxford
Frank RG, McGuire TG (1996) Introduction to the economics of mental health payment system. In: Levin BL, Petrila J (eds) Mental health services: a public health perspective. Oxford University Press, New York
Frank RG, Salkever D, Sharfstein S (1991) A new look at rising mental health insurance costs. Health Affairs 10: 116–123
Geraty RD, Hendren RL, Flaa CJ (1992) Ethical perspectives on managed care as it relates to child and adolescent psychiatry. J Am Acad Child Adolesc Psychiatry 31: 398–402
Gray A, Marshall M, Lockwood A, Morris J (1997) Problems in conducting economic evaluations alongside clinical trials: lessons from a study of case management for people with mental disorders. Br J Psychiatry 170: 47–52
Häfner H, an der Heiden W (1989) Effectiveness and cost of community care for schizophrenia patients. Hosp Community Psychiatry 40: 59–63
Heinrich K, Linden M, Müller-Oerlinghausen B (1989) Werden zu viele Psychopharmaka verordnet? Methoden und Ergebnisse der Pharmakoepidemiologie und Phase-IV-Forschung. Thieme, Stuttgart
Hess D, Ciompi L, Dauwalder H (1989) Nutzen- und Kostenevaluation eines sozialpsychiatrischen Dienstes. Nervenarzt 57: 204–213
Hoffmeyer U (1994) The health care system in Germany. In: Hoffmeyer U, McCarthy T (eds) Financing health care I. Kluver, Dordrecht
Hotopf M, Lewis G, Normand C (1996) Are SSRIs a cost-effective alternative to tricyclics? Br J Psychiatry 168: 404–409
Johnson S, Ramsay R, Thornicroft G, Brooks L, Lelliott P, Peck E, Smith H, Chisholm D, Audini B, Knapp MRJ, Goldberg D (1997) London’s mental health. King’s Fund, London
Kavanagh S, Stewart A (1995) Economic evaluations of mental health care. In: Knapp MRJ (ed) The economic evaluation of mental health care. Arena, Aldershot
Klein R (1995) Big bang health care reform — does it work? The case of Britain’s National Health Service reforms. Milbank Q 73: 299–337
Klerman GL, Weissman MM (1989) Increasing rates of depression. JAMA 261: 2229–2235
Knapp MRJ (1984) The economics of social care. Macmillan, London
Knapp MRJ (1995) The economic evaluation of mental health care. Arena, Aldershot
Knapp MRJ (1997a) Economic evaluation and interventions for children and adolescents with mental health problems. J Child Psychol Psychiatry 38(1): 3–26
Knapp MRJ (1997b) Economics and mental health: a concise European history of demand and supply. In: Tansella M (ed) Making mental health services rational. Pensiero Scientifico, Rome
Knapp MRJ, Beecham JK (1996) Programme-level and system-level health economics considerations. In: Knudson HC, Thornicroft G (eds) Mental health service evaluation. Cambridge University Press, Cambridge
Knapp MRJ, Beecham J, Koutsogeorgopoulou V, Hallam A, Fenyo A, Marks IM, Connolly J, Audini B, Muijen M (1994) Service use and costs of home-based versus hospital-based care for people with serious mental illness. Br J Psychiatry 165: 195–203
Knapp MRJ, Marks IM, Wolstenholme J, Beecham JK, Astin J, Audini B, Connolly J, Watts V (1998) Home-based versus hospital-based care for serious mental illness: a controlled cost-effectiveness study over four years. Br J Psychiatry 172: 506–512
Korman N, Glennerster H (1990) Hospital closure. Open University, Milton Keynes
Leff J (1997) Community care: illusion or reality? Wiley, Chichester
Leff J, Trieman N, Gooch C (1996) Prospective follow-up study of long-stay patients discharged from two psychiatric hospitals. Am J Psychiatry 153: 1318–1324
Lehman AF (1996) Measures of quality of life among persons with severe and persistent mental disorders. In: Thornicroft G, Tansella M (eds) Mental health outcome measures. Springer, Berlin Heidelberg New York, pp 75–92
Le Pen C, Levy E, Ravily V, Beuzen JN, Meurgey F (1994) The cost of treatment dropout in depression. A cost-benefit analysis of fluoxetine vs tricyclics. J Affective Disord 31: 1–18
Light D (1997) The real ethics of rationing. Br Med J 315: 112–115
Linden M, Gothe H (1993) Benzodiazepine substitution in medical practice: analysis of pharmacoepidemological data based on expert interviews. Pharmacopsychiatry 26: 107–113
Mari JJ, Streiner D (1996) The effects of family intervention on those with schizophrenia. In: Adams C, Anderson J, Mari JJ (eds) Schizophrenia module. Cochrane Database of Systematic Reviews. Cochrane Library, London
Marks IM, Connolly J, Muijen M, McNamee G, Audini B, Lawrence RE (1994) Home-based versus hospital-based care for people with serious mental illness. Br J Psychiatry 165: 179–194
Maynard A, Marinker M, Gray DP (1986) The doctor, the patient and their contract. Br Med J 292: 1438–1440
⋆McGuire A, Henderson J, Mooney G (1988) The economics of health care. Routledge, London
McPhillips MA, Sensky T (1997) Coercion, adherence or collaboration? Influences on compliance with medication. In: Wykes T (ed) Outcome and innovation in psychological treatment of schizophrenia. Wiley, Chichester
Mehrez A, Gafni A (1989) Quality-adjusted life years, utility theory and healthy-year equivalents. Med Decis Making 9: 142–149
National Health Service Executive (1996) Burdens of disease. National Health Service Executive, London
Netten A, Dennett JH (1997) Unit costs of health and social care 1997. Personal Social Services Research Unit, University of Kent, Canterbury
Offord DR, Boyle MH, Racine YA, Fleming JE, Cadman DT, Munroe Blum H, Byrne C, Links PS, Lipman EL, MacMillan HL, Rae Grant NI, Sanford MN, Szatmari P, Thomas H, Woodward CA (1992) Outcome, prognosis and risk in a longitudinal follow-up study. J Am Acad Child Adoles Psychiatry 31: 916–923
Padgett DK, Patrick C, Burns BJ, Schlesinger HJ, Cohen J (1993) The effect of insurance benefit changes on use of child and adolescent outpatient mental health services. Med Care 31: 96–110
Priebe S (1994) Die Bedeutung der Lebensqualität für psychiatrische Versorgung und Forschung. Psychiatr Prax 21: 87
Priebe S, Hoffman K, Isermann M, Kaiser W (1996) Klinische Merkmale langzeithospitalisierter Patienten. Psychiatr Prax 23: 15–20
Revicki DA, Brown RE, Palmer W et al (1995) Modelling the cost effectiveness of antidepressant treatment in primary care. Pharmacoeconomics 8: 524–540
Revicki DA, Shakespeare A, Kind P (1996) Preferences for schizophrenia-related health states: a comparison of patients, caregivers and psychiatrists. Int Clin Psychopharmacol 11: 101–108
Rice DP, Kelman S, Miller LS (1990) The economic costs of alcohol and drug abuse and mental illness 1985. National Institute of Mental Health, Rockville, MD
Ritchie J, Kick D, Lingham R (1994) The report of the inquiry into the care and treatment of Christopher Clunis. HMSO, London
Rössler W, Salize JH (1994) Longitudinal statistics of mental health care in Germany. Soc Psychiatry Psychiatr Epidemiol 29: 112–118
Rössler W, Salize HJ, Bauer M (1996) Psychiatrische Abteilungen an Allgemeinkrankenhäusern — Stand der Entwicklung in Deutschland. Psychiatr Prax 23: 4–9
Ryan M (1996) Using conjoint analysis to establish consumer preferences. Office of Health Economics, London
Sabin JE (1994) A credo for ethical managed care in mental health practice. Hosp Community Psychiatry 45: 859–860
Salize HJ, Rössler W (1995) The cost of comprehensive care of people with schizophrenia living in the community: a cost evaluation from a German catchment area. Br J Psychiatry 169: 42–48
Sayce L (1995) Response to violence: a framework for fair treatment. In: Crichton J (ed) Psychiatric patient violence: risk and response. Duckworth, London
Sclar DA, Robison LM, Skaer TL, Legg RF, Nemec NL, Galin RS, Hughes TE, Buesching DP (1994) Antidepressant pharmacotherapy: economic outcomes in a health maintenance organisation. Clin Ther 16: 715–730
Sclar DA, Robison LM, Skaer TL, Galin RS, Legg RF, Nemec NL, Highes TE, Buesching DP, Morgan M (1995) Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organisation. J Int Med Res 23: 395–412
Scott JE, Dixon LB (1995) Assertive community treatment and case management for schizophrenia. Schizophr Bull 21: 657–668
Sheldon T (1996) Problems of using modelling in the economic evaluation of health care. Health Econ 5: 1–12
Simon GE, Von Korff M, Heiligenstein JH, Revicki DA, Grothaus L, Katon W, Wagner EH (1996) Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 275: 1897–1902
Stein LI, Test M (1980) Alternative to mental hospital treatment. Arch Gen Psychiatry 37: 392–397
Beck B (1996) The economics of ageing. The Economist (27th January 1996): 3–16
Tillett R (1996) Psychotherapy assessment and treatment selection. Br J Psychiatry 168: 10–15
Unützer J, Tischler GL (1996) The many faces of managed care. In: Moscarelli M, Rupp A, Sartorius N (eds) Handbook of mental health economics and policy: schizophrenia. Wiley, Chichester
Weisbrod BA, Test MA, Stein LI (1980) Alternative to mental hospital treatment. II. Economic benefit-cost analysis. Arch Gen Psychiatry 37: 400–405
Wissenschaftliches Institut der Ortskrankenkassen (1986) Krankenhäuser 1984: Ein statistischer Spiegel. Wissenschaftliches Institut der Ortskrankenkassen, Bonn
World Bank (1993) World development report: investing in health. Oxford University Press, Oxford
World Health Organization (1982) Changing patterns in suicide behaviour. WHO/Euro Report no 74. World Health Organization, Geneva
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Knapp, M. (2001). Economic Evaluation of Mental Health Care. In: Henn, F., Sartorius, N., Helmchen, H., Lauter, H. (eds) Contemporary Psychiatry. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59519-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-59519-6_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64007-0
Online ISBN: 978-3-642-59519-6
eBook Packages: Springer Book Archive